Blue Trust’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
Other funds holding ATHE
Blue Trust's ATHE Position: Q3 2026 in Review
Blue Trust held its Alterity Therapeutics (ATHE) position steady in Q3 2026 at 40 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #2398.
Blue Trust first reported a position in ATHE in Q3 2024 and has held it in 9 quarters since. The position peaked at $215 in Q2 2026. 18 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.
- Blue Trust held 40 shares of Alterity Therapeutics worth $146 as of Q3 2026.
- Blue Trust left its Alterity Therapeutics share count unchanged in Q3 2026.
- Alterity Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2398 holding.
- Blue Trust first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 9 quarters since.
- Blue Trust's Alterity Therapeutics position peaked at $215 in Q2 2026.
- 18 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.